BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22508870)

  • 1. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
    Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
    Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs' micrographic surgery for nonmelanoma skin cancers.
    Nelson BR; Railan D; Cohen S
    Clin Plast Surg; 1997 Oct; 24(4):705-18. PubMed ID: 9342512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
    Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
    Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007).
    Lim P; Paver R; PeƱas PF
    J Am Acad Dermatol; 2010 Nov; 63(5):832-5. PubMed ID: 20950738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mohs micrographic surgery: How ACMS fellowship directors practice.
    Casey AS; Kennedy CE; Goldman GD
    Dermatol Surg; 2009 May; 35(5):747-56. PubMed ID: 19389108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
    Duffy KL; McKenna JK; Hadley ML; Tristani-Firouzi P
    Dermatol Surg; 2009 Jan; 35(1):30-3. PubMed ID: 19018813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015.
    Wang DM; Morgan FC; Besaw RJ; Schmults CD
    J Am Acad Dermatol; 2018 Jan; 78(1):47-53. PubMed ID: 28947293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
    Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
    JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
    Zabielinski M; Leithauser L; Godsey T; Gloster HM
    Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor characteristics of Mohs surgery patients in Ottawa, Canada versus Houston, Texas--a consequence of access to care?
    Beach RA; Zhang T; Goldberg LH; Walker JD; Mamelak AJ
    Dermatol Surg; 2011 Aug; 37(8):1106-12. PubMed ID: 21635629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
    Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
    Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in tumor and patient characteristics in those undergoing Mohs surgery.
    Lee KC; Higgins HW; Linden O; Cruz AP
    Dermatol Surg; 2014 Jun; 40(6):686-90. PubMed ID: 24852474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
    Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
    Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mohs micrographic surgery utilization in the Medicare population, 2009.
    Donaldson MR; Coldiron BM
    Dermatol Surg; 2012 Sep; 38(9):1427-34. PubMed ID: 22681892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs versus surgical excision in nonmelanoma skin cancers: does location matter?
    Pereira CT; Kruger EA; Sayer G; Kim J; Hu J; Miller TA; Rudkin GH
    Ann Plast Surg; 2013 Apr; 70(4):432-4. PubMed ID: 23486132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location.
    Theroux ZA; Blechman AB; Russell MA
    Dermatol Surg; 2019 Jan; 45(1):36-43. PubMed ID: 29894432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.